Trial Profile
Flexible dosed duloxetine versus placebo in the treatment of fibromyalgia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Oct 2011
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Fibromyalgia; Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 08 May 2010 Results were presented at the 29th Annual Scientific Meeting of the American Pain Society.
- 19 Aug 2009 Actual patient number (513) added as reported by ClinicalTrials.gov.
- 19 Aug 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.